An off-label question · prescriber territory · no dosing anywhere here
The panel says not to put it there
Topical minoxidil is sold over the counter for the top of the scalp. Its own Drug Facts panel, under "When using this product", says not to apply it on other parts of the body. This page is about what that sentence means, who is allowed to decide otherwise, and why this site will not tell you how to use it.
Money notice. Further down, one shop is named through an affiliate programme — marked sponsored and nofollow — and a purchase made after following it earns this desk a cut. It is named as an example of a product category, never as something that works: nothing on this page says those products grow facial hair. The full accounting, refusals included.
Jump to a section
Read off the drug labels themselves, not off anybody’s marketing. Approval is a statement about a document, not about whether something works.
Two of the four rows have no approved product at all. That is the reason this site exists, and it is also the reason no page here tells you what to put on your face.
Topical minoxidil sold in the United States without a prescription is labelled for the top of the scalp, and its panel tells the buyer not to apply it on other parts of the body. A jaw, a lip and a brow are other parts of the body. That is the whole of the regulatory position, and everything else on this page follows from it.
This is not the same as saying the drug does nothing on a face. It is saying something narrower and more useful: no regulator has examined that use, so nobody has a label to point at, which means the decision moves from a shelf to a prescriber. This page explains that distinction and stops there. It contains no amount, no frequency and no strength offered as a recommendation, on purpose.
What the panel actually says
Over-the-counter drugs in the United States carry a standardised Drug Facts panel, and the panels for topical minoxidil are public documents you can read for yourself on DailyMed. Taking the 5% solution marketed for men as the example, the panel gives the Use as regrowing hair on the top of the scalp, vertex only, and refers the reader to the pictures on the carton.
Under When using this product, the same panel carries two lines that matter more to a face than anything else on it. The first is "do not apply on other parts of the body". The second is "avoid contact with the eyes", with an instruction to rinse with large amounts of cool tap water if contact happens. On a scalp that second line is a precaution about drips. On a brow it is a description of the treatment area's immediate neighbour.
The panel also carries a line that is easy to read past and is arguably the most interesting sentence in the document for this site's purposes. Among the reasons to stop and ask a doctor, it lists unwanted facial hair growth. The manufacturers of a scalp product considered hair appearing on a face to be an unwanted effect worth warning a buyer about — while a separate market sells the same molecule to people who want exactly that. Both things are true at once, and the label is the honest half.
The panels are not all identical
It is worth knowing that these documents differ between products in ways that make a nonsense of any single confident summary. The men's 5% solution panel tells a buyer to stop and ask a doctor if there is no regrowth in four months. A 5% foam panel from a different labeller sets the same checkpoint at six months. The men's solution panel says plainly, under Do not use, "you are a woman", and carries the warning "For use by men only".
Anyone quoting "the minoxidil label" as a single fixed thing — including anyone telling you what it permits on a face — is summarising documents they should be pointing you at instead. The panel on the product in your hand is the one that applies to you, and it is printed on the carton.
Off-label is a real category, not a loophole
Using an approved drug outside the terms of its approval is lawful and commonplace in medicine. It is not a scandal. But it is a decision that belongs to a prescriber, because the person making it is taking on the job the regulator did not do: weighing the evidence, the person's own history, and what to watch for, without a label to lean on.
The practical consequence for a reader is unglamorous. If you want to use a scalp product on your face, the route that carries any protection at all runs through somebody who can examine your face and knows what else you take. That appointment is the honest answer to the question this page gets asked, and it pays this site nothing whatsoever.
The compounding warning that bears on faces
There is a second product category worth naming, because it is marketed heavily for hair and it is where the face-specific risks get sharpest. Compounded topicals — mixtures made up by a compounding pharmacy rather than manufactured to an approved formula — are frequently sold combining finasteride with minoxidil.
The United States Food and Drug Administration published an alert about compounded topical finasteride products, its content current as of 22 April 2025. It states that "there is no FDA-approved topical formulation of finasteride", that it had received 32 reports to its adverse event reporting system between 2019 and 2024, and that "absorption of finasteride through the skin into the bloodstream is expected". It also records that "most of the reports FDA has received state the adverse events continued to persist after product discontinuation".
The part that belongs on a page about faces is the transfer warning. The alert describes a greater potential risk of inadvertent exposure to others, specifically females, through transfer of applied product — because a compounded topical has none of the coating that keeps an approved tablet from contacting anyone handling it. A drug applied to the lower half of a face is applied to the part of a person that touches other people.
None of that is an argument that any particular product is unsafe for you. It is an argument that the question is a clinician's, and that a page selling you something is the worst place to have it answered.
What the shops actually sell for faces
Walk the other way — away from drugs — and the facial-hair aisle is a cosmetics aisle. That word is doing legal work. A cosmetic is sold to improve appearance; a drug is sold to change how the body works, and only a drug has to prove anything to a regulator before it is sold. The products marketed for beards and brows are almost entirely in the first category, and their names say so if you read them: they are conditioning serums, not growth treatments.
As one example you can inspect yourself, DS Laboratories openly sells beard and eyebrow conditioning serums alongside its scalp range. That link is paid: it is marked sponsored and nofollow, and this site earns a share if someone buys after following it. It is here because the company is a clear, checkable example of the category this section is about — and it is worth being blunt that this site has no evidence that any of those products grows facial hair, and nothing on this page says they do. A conditioning claim is a claim about how hair looks and feels. It is not a claim about making more of it, and it was never assessed as one.
The link this site turned down
Brow & Jaw was offered the affiliate programme for generic over-the-counter products, which in this lane means minoxidil, and refused it.
The reasoning is on the disclosure page in full, and it is short: this page's central fact is that the panel excludes the face. Earning a commission on sending readers to buy that product for their face would make this page an advertisement arguing against itself. Saying so out loud is the point: taking the money later would mean going back and editing the disclosure page first, where anyone can see it happen.